# US 2023/0404536 A1 · Method for renal cell carcinoma diagnosis by means of ultrasonic signals analysis and ultrasound images

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0404536 A1
- Document ID: US20230404536A1
- Status: Published application
- Kind: A1
- Application number: 18/037,741
- Filed: 2021-11-24
- Published: 2023-12-21
- Earliest claimed: 2020-12-01
- Assignees: Imedicals S.r.l.
- Applicants: Imedicals S.r.l.
- Inventors: Sergio Casciaro
- Web page: https://patentgrep.com/patent/US20230404536A1

## CPC

- A61B 8/5207: {involving processing of raw data to produce diagnostic data, e.g. for generating an image}
- A61B 8/085: {for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules}
- A61B 8/5246: {combining images from the same or different imaging techniques, e.g. color Doppler and B-mode}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An ultrasound device for carrying out a renal diagnostic examination for the diagnosis of renal cell carcinoma, comprising at least an ultrasound probe and relative control means, acquiring and storing means of the ultrasonic signals reflected by the tissues, it is configured to carry out the following acquisition procedure: transmitting at least one broadband ultrasonic pulse beam towards the patient's kidney, receiving and storing the raw ultrasonic signals reflected by the renal tissue and processing said signals to obtain a renal ultrasound image, -while keeping the probe in the same position, transmitting a narrow band ultrasonic pulse beam towards the patient's kidney, receiving and storing the ultrasonic signals reflected by the renal tissue in response to the narrow band ultrasonic pulse beam sent at point 130), and characterized in that it is configured to carry out a calculation method of a diagnostic parameter.

## Claims

### Claim 1

An ultrasound device for carrying out a renal diagnostic examination for the diagnosis of renal cell carcinoma, comprising:
at least one ultrasound probe, comprising a plurality of piezoelectric or CMUT transducers,
control means configured to drive said probe,
means for acquiring and storing ultrasonic signals reflected by the tissues, configured to carry out the following acquisition procedure:
100) transmitting at least one broadband ultrasonic pulse beam towards the patient's kidney;
110) receiving the ultrasonic signals reflected by the renal tissue in response to said pulse beam sent at point (100);
120) processing the signals stored at point 110), to obtain a renal B-mode ultrasound image
characterized in that
said procedure at point 110) also involves storing raw ultrasonic signals as received by said probe, before the processing steps to obtain the B-mode ultrasound image, and in that said procedure further comprises steps:
130) while keeping the probe in the same position, transmitting a narrow band ultrasonic pulse beam towards the patient's kidney;
140) receiving and storing the raw ultrasonic signals reflected by the renal tissue in response to the narrow band ultrasonic pulse beam sent at point 130), and further characterized in that it comprises also computing means on which suitable computer programs are loaded, which are configured to carry out the calculation method of a diagnostic parameter, comprising the following steps of:
200) analysis of said raw ultrasonic signals reflected in response to said broadband pulse beam, stored at point 110) to individuate one or more suspect regions, by means of the analysis of the statistical distribution of the coefficients of the associated wavelet transform,
for each suspect region:
210) extraction from said raw ultrasonic signals reflected by the renal tissue in response to the narrow band ultrasonic pulse beam, stored at point 140) of the signal relating to at least one segment contained in the suspect region;
220) execution of the frequency transform of the signal extracted at point 210), 230) extraction from said spectrum calculated at point 220) of the values relating to a plurality of significant frequencies;
240) extraction from said raw ultrasonic signals reflected by the renal tissue in response to broadband signals stored at point 110) of the signal relating to at least one segment contained in the suspect region;
250) calculation of the frequency transform of the signal extracted at point 240) to obtain at least one frequency spectrum obtained in response to said at least one broadband ultrasonic pulse;
260) calculation of one or more descriptive parameters of the spectrum calculated at point 250),
270) calculation of a diagnostic parameter indicating the tumor presence and type as a function of said values extracted at point 230) and of said descriptive parameters calculated at point 260).

### Claim 2 (depends on 1)

The ultrasound device according to claim 1, wherein said significant frequencies of point 230) comprise:
the nominal frequency of said narrow band signal;
the first harmonic of said nominal frequency;
the first sub-harmonic of said nominal frequency.

### Claim 3 (depends on 1)

The ultrasound device according to claim 1, wherein said diagnostic parameter calculated at point 270) is obtained as a function of one or more of the following parameters:
longitudinal dimension of said suspect region;
transversal dimension of said suspect region;
surface area of said suspect region;
ratio between the surface area and length of said suspect region edges;
ratio between the intensity of the first harmonic (ω1) and the intensity of the nominal frequency (ωn) of the frequency spectrum obtained in response to a narrow band ultrasonic signal calculated at point 220);
ratio between the intensity of the first sub-harmonic (ωsub1) and the intensity of the nominal frequency (ωn) of the frequency spectrum obtained in response to a narrow band ultrasonic signal calculated at point 220);
said parameters extracted at point 260).

### Claim 4 (depends on 3)

The ultrasound device according to claim 3, wherein said diagnostic parameter is calculated by comparing said parameters with the analogous parameters related to ultrasonic signals corresponding to:
a plurality of regions, for which the carcinoma outcome has been confirmed by subsequent histological examination;
a plurality of regions relating to a homogeneous, and reasonably healthy, renal tissue.

### Claim 5 (depends on 2)

The ultrasound device according to claim 2, wherein the nominal frequency of said probe is equal to 3.5 MHz, the effective band used for broadband acquisition is between 0 and 7 MHz and the frequency used for the transmission of narrow band pulses is equal to 3 MHz.

### Claim 6 (depends on 1)

The ultrasound device according to claim 1, wherein suspect regions are hypoechoic or hyperechoic regions with respect to the surrounding renal parenchyma.

### Claim 7 (depends on 6)

The ultrasound device according to claim 6, wherein said individuation of said suspect regions is obtained by means of the method according to the following steps:
499) decomposition by means of DWPT wavelet transform of the ““raw”” ultrasonic broadband reflected signal received by each of said piezoelectric or CMUT transducers in a plurality (n) of frequency bands, and calculation for each sampling instant of said signal of a plurality (n) of DWPT coefficients (kixy),
500) definition of a mobile analysis window in the ultrasound image plane,
510) definition of an advancement step of said mobile analysis window for each of the two directions,
520) with said mobile analysis window positioned in a first position of the ultrasound image:
521) identification of the values of said DWPT coefficients (kixy) associated to each one of the points contained inside said mobile window, thus defining a plurality (n) of sets of DWPT coefficients associated to the specific position of the window;
522) calculation, for each set of DWPT coefficients defined at point 521), of at least one statistical descriptor chosen among: average value, median value, modal value, minimum value, maximum value, standard deviation, skewness, kurtosis,
530) advancement of said window defined at point 500) along one of the two advancement directions by an amount equal to the respective step defined at point 510),
540) repetition of steps from 520) to 530), with advancements along the one or the other direction, until the whole region of interest, coincident with the kidney, has been covered by the mobile acquisition window;
550) for each one of the descriptors calculated at points 520) to 540), realization of an image obtained by associating the value of the descriptor to the point of the ultrasound image associated to the window the descriptor was calculated for;
560) analysis of each of said images obtained at point 550) to individuate one or more not homogeneous regions with respect to the surrounding region.

### Claim 8 (depends on 1)

The ultrasound device according to any one of the preceding claim 1, wherein said descriptive parameters calculated at point
260) comprise one or more of the following parameters:
spectrum average value;
area subtended by the spectrum in a determined frequency interval;
spectrum width at a predetermined intensity level;
frequency corresponding to the maximum value of said spectrum;
slope of a line interpolating a plurality of points of said spectrum in a predetermined frequency interval;
coefficients of a polynomial interpolating the points of said frequency spectrum in a frequency interval containing the maximum of said spectrum.

### Claim 9

The ultrasound device according to any one of the preceding claims, characterized in that said diagnostic parameter of point 270) is calculated by means of the following steps of:
410) definition of a series of parameters relating to a generic segment of a propagation line of the ultrasonic signal contained inside the renal tissue, comprising:
at least one of the statistical descriptors calculated at point 522) and associated to the segment of propagation line examined;
the ratio between the intensity of the first harmonic (ω1) and the intensity of the nominal frequency (ωn) of said raw ultrasonic signals as received by said probe;
the ratio between the intensity of the first sub-harmonic (ωsub1) and the intensity of the nominal frequency (ωn) of the raw ultrasonic signal reflected in response to a narrowband pulse;
the average value of the frequency spectrum of the raw ultrasonic signal reflected in response to a broadband pulse;
area subtended by the frequency spectrum of the broadband reflected raw ultrasonic signal in a determined frequency interval and/or in a determined amplitude interval;
spectrum width at a predetermined intensity level,
frequency corresponding to the maximum value of said frequency spectrum of the broadband reflected raw ultrasonic signal;
slope of a line interpolating a plurality of points of said frequency spectrum of the broadband reflected raw ultrasonic signal in a predetermined frequency interval;
the coefficients of a polynomial interpolating the points of said frequency spectrum of the broadband reflected raw ultrasonic signal in a frequency interval containing the maximum of said spectrum,
420) training of a neural network, by using a set of data containing the parameters defined at point 400) relating to a plurality of regions for which the result of the renal cell carcinoma has been confirmed by subsequent histological examination and for a plurality of regions relating to a homogeneous, and reasonably healthy, renal tissue;
430) presentation to said neural network of the set of data relating to each not homogeneous region individuated at point 340),
440) classification of the not homogeneous region as renal cell carcinoma or as healthy tissue, as a function of the network output.
